Local infusion of an α-1 adrenergic agonist into the prefrontal cortex impairs spatial working memory performance in monkeys
暂无分享,去创建一个
[1] A. Arnsten,et al. Behavioral and receptor binding analysis of the α2-adrenergic agonist, 5-bromo-6 [2-imidazoline-2-YL amino] quinoxaline (UK-14304): evidence for cognitive enhancement at an α2-adrenoceptor subtype , 1991, Neuropharmacology.
[2] H. E. Rosvold,et al. Localization of function within the dorsolateral prefrontal cortex of the rhesus monkey. , 1970, Experimental neurology.
[3] H. Tanila,et al. The effects of prefrontal intracortical microinjections of an alpha-2 agonist, alpha-2 antagonist and lidocaine on the delayed alternation performance of aged rats , 1996, Brain Research Bulletin.
[4] A. Arnsten,et al. Catecholamine regulation of the prefrontal cortex , 1997, Journal of psychopharmacology.
[5] F. Plum. Handbook of Physiology. , 1960 .
[6] J. Jentsch,et al. The Alpha-1 Adrenergic Agonist, Cirazoline, Impairs Spatial Working Memory Performance in Aged Monkeys , 1997, Pharmacology Biochemistry and Behavior.
[7] H. Tanila,et al. Medetomidine, atipamezole, and guanfacine in delayed response performance of aged monkeys , 1996, Pharmacology Biochemistry and Behavior.
[8] J. Schildkraut. Biogenic amines and affective disorders. , 1974, Annual review of medicine.
[9] A. Arnsten. Behavioral and receptor binding analysis of the α-2 adrenergic agonist, UK-14304 (5 bromo-6 [2-imidazoline-2-yl-amino]quinoxaline): evidence for cognitive enhancement at an α-2 adrenoceptor subtype. , 1991 .
[10] P. Goldman-Rakic,et al. Alpha 2-adrenergic mechanisms in prefrontal cortex associated with cognitive decline in aged nonhuman primates. , 1985, Science.
[11] F. Goodwin,et al. Cerebrospinal fluid norepinephrine in affective illness. , 1978, The American journal of psychiatry.
[12] S. Kish,et al. Reduced brain 5-HT and elevated NE turnover and metabolites in bipolar affective disorder , 1994, Biological Psychiatry.
[13] C. A. Morgan,et al. Noradrenergic and serotonergic function in posttraumatic stress disorder. , 1997, Archives of general psychiatry.
[14] J. Steere,et al. The α-2A noradrenergic receptor agonist guanfacine improves visual object discrimination reversal performance in aged rhesus monkeys. , 1997 .
[15] A. Arnsten. The Biology of Being Frazzled , 1998, Science.
[16] J. Cai,et al. Reserpine impairs spatial working memory performance in monkeys: reversal by the α2-adrenergic agonist clonidine , 1993, Brain Research.
[17] L H Staib,et al. Positron emission tomography measurement of cerebral metabolic correlates of yohimbine administration in combat-related posttraumatic stress disorder. , 1997, Archives of general psychiatry.
[18] A. Arnsten,et al. Noradrenergic influences on prefrontal cortical cognitive function: opposing actions at postjunctional alpha 1 versus alpha 2-adrenergic receptors. , 1998, Advances in pharmacology.
[19] Bao-Ming Li,et al. Delayed-response deficit induced by local injection of the alpha 2-adrenergic antagonist yohimbine into the dorsolateral prefrontal cortex in young adult monkeys. , 1994, Behavioral and neural biology.
[20] C. A. Morgan,et al. Noradrenergic Alterations in Posttraumatic Stress Disorder , 1997, Annals of the New York Academy of Sciences.
[21] JaneR . Taylor,et al. A role for norepinephrine in stress-induced cognitive deficits: α-1-adrenoceptor mediation in the prefrontal cortex , 1999, Biological Psychiatry.
[22] F. Goodwin,et al. Central Norepinephrine Metabolism in Affective Illness: MHPG in the Cerebrospinal Fluid , 1973, Science.
[23] P. Goldman-Rakic,et al. The alpha-2 adrenergic agonist guanfacine improves memory in aged monkeys without sedative or hypotensive side effects: evidence for alpha-2 receptor subtypes , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[24] J. Krystal,et al. The biological basis of panic disorder. , 1996, The Journal of clinical psychiatry.
[25] JaneR . Taylor,et al. α-1 noradrenergic receptor stimulation impairs prefrontal cortical cognitive function , 1999, Biological Psychiatry.
[26] A. Arnsten,et al. The α-2a noradrenergic agonist, guanfacine, improves delayed response performance in young adult rhesus monkeys , 1998, Psychopharmacology.
[27] R. D. Hunt,et al. The Contribution of α2-Noradrenergic Mechanisms to Prefrontal Cortical Cognitive Function: Potential Significance for Attention-Deficit Hyperactivity Disorder , 1996 .